Piramal Pharma Limited Announces Results for Q4 and Full-year FY26
MUMBAI, India, April 29, 2026 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the Fourth Quarter (Q4)...